A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
- PMID: 30545401
- PMCID: PMC6292067
- DOI: 10.1186/s40168-018-0603-4
A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
Abstract
Background: Immune-mediated inflammatory disease (IMID) represents a substantial health concern. It is widely recognized that IMID patients are at a higher risk for developing secondary inflammation-related conditions. While an ambiguous etiology is common to all IMIDs, in recent years, considerable knowledge has emerged regarding the plausible role of the gut microbiome in IMIDs. This study used 16S rRNA gene amplicon sequencing to compare the gut microbiota of patients with Crohn's disease (CD; N = 20), ulcerative colitis (UC; N = 19), multiple sclerosis (MS; N = 19), and rheumatoid arthritis (RA; N = 21) versus healthy controls (HC; N = 23). Biological replicates were collected from participants within a 2-month interval. This study aimed to identify common (or unique) taxonomic biomarkers of IMIDs using both differential abundance testing and a machine learning approach.
Results: Significant microbial community differences between cohorts were observed (pseudo F = 4.56; p = 0.01). Richness and diversity were significantly different between cohorts (pFDR < 0.001) and were lowest in CD while highest in HC. Abundances of Actinomyces, Eggerthella, Clostridium III, Faecalicoccus, and Streptococcus (pFDR < 0.001) were significantly higher in all disease cohorts relative to HC, whereas significantly lower abundances were observed for Gemmiger, Lachnospira, and Sporobacter (pFDR < 0.001). Several taxa were found to be differentially abundant in IMIDs versus HC including significantly higher abundances of Intestinibacter in CD, Bifidobacterium in UC, and unclassified Erysipelotrichaceae in MS and significantly lower abundances of Coprococcus in CD, Dialister in MS, and Roseburia in RA. A machine learning approach to classify disease versus HC was highest for CD (AUC = 0.93 and AUC = 0.95 for OTU and genus features, respectively) followed by MS, RA, and UC. Gemmiger and Faecalicoccus were identified as important features for classification of subjects to CD and HC. In general, features identified by differential abundance testing were consistent with machine learning feature importance.
Conclusions: This study identified several gut microbial taxa with differential abundance patterns common to IMIDs. We also found differentially abundant taxa between IMIDs. These taxa may serve as biomarkers for the detection and diagnosis of IMIDs and suggest there may be a common component to IMID etiology.
Keywords: 16S rRNA gene amplicon sequencing; Bacteria; Gut microbiota; Immune-mediated inflammatory disease; Inflammatory bowel disease; Machine learning classifiers; Multiple sclerosis; Rheumatoid arthritis; Taxonomic biomarkers.
Conflict of interest statement
Ethics approval and consent to participate
Written informed consent was obtained from patients and healthy controls prior to sample collection. The University of Manitoba’s Research Ethics Board approved this study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures




Similar articles
-
Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity.BMC Microbiol. 2024 Jul 19;24(1):268. doi: 10.1186/s12866-024-03425-y. BMC Microbiol. 2024. PMID: 39030520 Free PMC article.
-
Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.Nutrients. 2022 Jan 8;14(2):260. doi: 10.3390/nu14020260. Nutrients. 2022. PMID: 35057440 Free PMC article.
-
Dysbiotic signatures and diagnostic potential of gut microbial markers for inflammatory bowel disease in Korean population.Sci Rep. 2024 Oct 10;14(1):23701. doi: 10.1038/s41598-024-74002-6. Sci Rep. 2024. PMID: 39390011 Free PMC article.
-
Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease.Nutrients. 2024 Jun 30;16(13):2092. doi: 10.3390/nu16132092. Nutrients. 2024. PMID: 38999840 Free PMC article. Review.
-
Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.Dis Markers. 2020 Aug 27;2020:3936247. doi: 10.1155/2020/3936247. eCollection 2020. Dis Markers. 2020. PMID: 32908614 Free PMC article.
Cited by
-
Interplay of Good Bacteria and Central Nervous System: Cognitive Aspects and Mechanistic Considerations.Front Neurosci. 2021 Feb 11;15:613120. doi: 10.3389/fnins.2021.613120. eCollection 2021. Front Neurosci. 2021. PMID: 33642976 Free PMC article. Review.
-
Gut Microbiome Composition Associated With Major Depressive Disorder and Sleep Quality.Front Psychiatry. 2021 May 21;12:645045. doi: 10.3389/fpsyt.2021.645045. eCollection 2021. Front Psychiatry. 2021. PMID: 34093266 Free PMC article.
-
Association between Gut Microbiota and Biological Aging: A Two-Sample Mendelian Randomization Study.Microorganisms. 2024 Feb 11;12(2):370. doi: 10.3390/microorganisms12020370. Microorganisms. 2024. PMID: 38399774 Free PMC article.
-
Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis.Commun Med (Lond). 2024 Jul 19;4(1):148. doi: 10.1038/s43856-024-00565-0. Commun Med (Lond). 2024. PMID: 39030379 Free PMC article.
-
Supplemental Xylooligosaccharide Modulates Intestinal Mucosal Barrier and Cecal Microbiota in Laying Hens Fed Oxidized Fish Oil.Front Microbiol. 2021 Feb 22;12:635333. doi: 10.3389/fmicb.2021.635333. eCollection 2021. Front Microbiol. 2021. PMID: 33692770 Free PMC article.
References
-
- Wraith DC. The future of immunotherapy: a 20-year perspective. Front Immunol. 2017;8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712390/. Cited 15 Mar 2018. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical